FindTrial
Sign In

The effectiveness of short-course treatment for tuberculous pleurisy: a cluster randomized controlled trial

The effectiveness of short-course treatment for tuberculous pleurisy: a cluster randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000029269
Enrollment
Unknown
Registered
2020-01-19
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculous pleurisy

Interventions

Short-course group:6 months short-course anti-tb regimen 2HRZE/4HR (E)
Long-course group:12 months long-course anti-tb regimen 2HRZE/10HR (E)

Sponsors

Beijing Chest Hospital affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients with tuberculous pleurisy who meet the clinical or diagnostic criteria of tuberculous pleurisy; (2) Aged 14-70 years; (3) Informed consent, voluntary subjects.

Exclusion criteria

Exclusion criteria: (1) Pregnant women; (2) Any patients with drug resistance to isoniazid,rifampicin or pyrazinamide; (3) Patients with extrapulmonary tuberculosis; (4) Patients who cannot be treated with either isoniazid,rifampicin or pyrazinamide at the beginning of treatment.

Design outcomes

Primary

MeasureTime frame
Cure rate;Recurrence rate;—

Countries

China

Contacts

Public ContactXiaoyou Chen

Beijing Chest Hospital,Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute; Beijing 101149, China.

kyb6295@sina.com+86 13911320562

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026